OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 58 filers reported holding OVID THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $323,743 | -8.0% | 84,308 | -21.4% | 0.00% | – |
| Q2 2023 | $351,885 | -59.8% | 107,282 | -68.4% | 0.00% | -100.0% |
| Q1 2023 | $875,033 | -7.1% | 339,160 | -33.0% | 0.00% | 0.0% |
| Q4 2022 | $941,769 | -26.0% | 506,327 | -26.8% | 0.00% | -50.0% |
| Q3 2022 | $1,272,000 | -33.5% | 691,323 | -22.3% | 0.00% | 0.0% |
| Q2 2022 | $1,912,000 | -31.5% | 889,364 | +0.1% | 0.00% | -33.3% |
| Q1 2022 | $2,791,000 | +14.6% | 888,701 | +17.1% | 0.00% | +50.0% |
| Q4 2021 | $2,436,000 | -0.5% | 759,096 | +4.1% | 0.00% | 0.0% |
| Q3 2021 | $2,449,000 | -16.0% | 728,930 | -2.3% | 0.00% | -33.3% |
| Q2 2021 | $2,917,000 | +23.9% | 745,915 | +27.4% | 0.00% | +50.0% |
| Q1 2021 | $2,355,000 | +380.6% | 585,705 | +175.8% | 0.00% | – |
| Q4 2020 | $490,000 | – | 212,393 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 1,380,346 | $3,516 | 18.08% |
| Madison Avenue Partners, LP | 3,104,603 | $8,009,876 | 1.72% |
| BVF INC/IL | 6,851,051 | $17,675,712 | 0.65% |
| CHI Advisors LLC | 864,822 | $2,231,241 | 0.59% |
| EcoR1 Capital, LLC | 6,117,400 | $15,782,892 | 0.51% |
| Rubric Capital Management LP | 7,001,124 | $18,062,900 | 0.47% |
| Artal Group S.A. | 2,500,000 | $6,450 | 0.38% |
| Tejara Capital Ltd | 118,791 | $306,481 | 0.16% |
| DCF Advisers, LLC | 68,264 | $176,120 | 0.11% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 827,580 | $2,135,156 | 0.06% |